- Coordinator
- Inspek, France
- Runs
- 1 January 2025 to 31 December 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 101188575
What the project is doing
In the project's own words, from its summary on CORDIS.
The growth of biomanufacturing, characterised by an ever-increasing number of bioproduced molecules including life-saving drugs, is hampered by high bioprocessing failure rates that incur over $2 billion in annual losses for companies like Johnson & Johnson. It is also associated with significant environmental impacts, particularly in sterilisation processes. Single-use technologies have emergedas a solution, yet they require advanced sensing capabilities for full effectiveness.
InSpek addresses this need with its multi-sensoron- a-chip technology, utilising waveguide-enhanced Raman spectroscopy (WERS) and Photonic Integrated Circuits (PIC). Our PICsintegrate essential bioprocessing sensors — Raman spectroscopy, temperature, pH, dissolved oxygen, and others — into a single, compact platform. InSpek's non-invasive technology outperforms traditional sensors in cost and efficiency, enhancing real-time bioprocess monitoring and reducing the development time for new biotherapies.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Inspek | Palaiseau | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI